Sign Up to like & get
recommendations!
0
Published in 2019 at "Digestion"
DOI: 10.1159/000502287
Abstract: Backgrounds/Aims: Vonoprazan (VPZ) is the first clinically available potassium competitive acid blocker. This class of agents provides faster and more potent acid inhibition than proton pump inhibitors. Most strains of Helicobacter pylori are sensitive to…
read more here.
Keywords:
eradication;
dual therapy;
vonoprazan amoxicillin;
therapy ... See more keywords